Elisa Pierpaoli (2022) “Determination of Antimetastatic and Antitumor Activities of Orally Administered NAX014 Compound in a Murine Model of HER2-Positive Breast Cancer”, Perspective of Recent Advances in Medical Research Vol. 2, pp. 109–127. doi: 10.9734/bpi/pramr/v2/3905C.